tiprankstipranks
Advertisement
Advertisement

HOWL Stock Latest News

Werewolf Therapeutics Faces Nasdaq Delisting Risk After Falling Below $1 Minimum Bid Price
Company AnnouncementsWerewolf Therapeutics Faces Nasdaq Delisting Risk After Falling Below $1 Minimum Bid Price
4M ago
HOWL
Werewolf Therapeutics hires Piper Sandler to assist in strategic evaluation
PremiumThe Fly
Werewolf Therapeutics hires Piper Sandler to assist in strategic evaluation
4M ago
HOWL
Werewolf Therapeutics reports Q4 EPS (20c), consensus (35c)
PremiumThe Fly
Werewolf Therapeutics reports Q4 EPS (20c), consensus (35c)
4M ago
HOWL
Werewolf Therapeutics to explore range of strategic alternatives
PremiumThe Fly
Werewolf Therapeutics to explore range of strategic alternatives
4M ago
HOWL
Werewolf Therapeutics, Inc. (HOWL) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Werewolf Therapeutics, Inc. (HOWL) Q4 Earnings Cheat Sheet
4M ago
HOWL
Werewolf Therapeutics to explore strategic alternatives
PremiumThe FlyWerewolf Therapeutics to explore strategic alternatives
5M ago
HOWL
Werewolf Therapeutics Begins Strategic Alternatives Review Process
Premium
Company Announcements
Werewolf Therapeutics Begins Strategic Alternatives Review Process
5M ago
8K
HOWL
Werewolf Therapeutics trading resumes
Premium
The Fly
Werewolf Therapeutics trading resumes
5M ago
HOWL
Werewolf Therapeutics trading halted, news pending
PremiumThe Fly
Werewolf Therapeutics trading halted, news pending
5M ago
HOWL
Werewolf Therapeutics Announces Major Workforce and Leadership Restructuring
PremiumCompany Announcements
Werewolf Therapeutics Announces Major Workforce and Leadership Restructuring
5M ago
8K
HOWL
Werewolf Therapeutics announces 64% workforce reduction
PremiumThe Fly
Werewolf Therapeutics announces 64% workforce reduction
5M ago
HOWL
Werewolf Therapeutics Receives Nasdaq Minimum Bid Price Notice
PremiumCompany Announcements
Werewolf Therapeutics Receives Nasdaq Minimum Bid Price Notice
5M ago
8K
HOWL
Citizens downgrades Werewolf Therapeutics on need for capital
PremiumThe FlyCitizens downgrades Werewolf Therapeutics on need for capital
7M ago
HOWL
Werewolf Therapeutics downgraded to Market Perform from Outperform at Citizens
Premium
The Fly
Werewolf Therapeutics downgraded to Market Perform from Outperform at Citizens
7M ago
HOWL
Wedbush downgrades Werewolf Therapeutics to Neutral on challenging path
Premium
The Fly
Wedbush downgrades Werewolf Therapeutics to Neutral on challenging path
7M ago
HOWL
Werewolf Therapeutics downgraded to Neutral from Outperform at Wedbush
PremiumThe Fly
Werewolf Therapeutics downgraded to Neutral from Outperform at Wedbush
7M ago
HOWL
Werewolf Therapeutics price target lowered to $4 from $10 at H.C. Wainwright
PremiumThe Fly
Werewolf Therapeutics price target lowered to $4 from $10 at H.C. Wainwright
7M ago
HOWL
Clinical Momentum and Platform Validation Drive Undervalued Upside at Werewolf Therapeutics
PremiumRatings
Clinical Momentum and Platform Validation Drive Undervalued Upside at Werewolf Therapeutics
7M ago
HOWL
Werewolf Therapeutics Updates Pipeline and Outlines 2026 Priorities
PremiumCompany Announcements
Werewolf Therapeutics Updates Pipeline and Outlines 2026 Priorities
7M ago
8K
HOWL
Werewolf Therapeutics provides pipeline update, review of INDUKINE data
PremiumThe FlyWerewolf Therapeutics provides pipeline update, review of INDUKINE data
7M ago
HOWL
Werewolf Therapeutics announces 2025 priorities
Premium
The Fly
Werewolf Therapeutics announces 2025 priorities
7M ago
HOWL
Werewolf Therapeutics price target lowered to $7 from $8 at BofA
Premium
The Fly
Werewolf Therapeutics price target lowered to $7 from $8 at BofA
8M ago
HOWL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >